139 related articles for article (PubMed ID: 33906629)
21. High-grade serous cancer of undetermined primary origin presenting as solitary inguinal lymph node enlargement.
Dam K; Peeters F; Verhoeven D; Duwel V
BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33910789
[TBL] [Abstract][Full Text] [Related]
22. Prevention of Oncogenic
Atamna A; Yahav D; Hirzel C
Transpl Int; 2023; 36():11856. PubMed ID: 38046068
[TBL] [Abstract][Full Text] [Related]
23. Cavity-based lymphomas: challenges and novel concepts. A report of the 2022 EA4HP/SH lymphoma workshop.
Di Napoli A; Soma L; Quintanilla-Martinez L; de Leval L; Leoncini L; Zamò A; Ng SB; Ondrejka SL; Climent F; Wotherspoon A; Dirnhofer S
Virchows Arch; 2023 Sep; 483(3):299-316. PubMed ID: 37555981
[TBL] [Abstract][Full Text] [Related]
24. Primary Effusion Lymphoma in an HIV-Negative Patient with Chronic Myeloid Leukemia Treated with Dasatinib.
SahBandar IN; Sy CB; van den Akker T; Kim D; Geyer JT; Chadburn A; Cesarman E; Inghirami G; Allan JN; Siddiqui MT; Ouseph MM
Pathobiology; 2023; 90(5):356-364. PubMed ID: 36996787
[TBL] [Abstract][Full Text] [Related]
25. Primary Effusion Lymphoma: A Rare and Challenging Diagnosis for Recurrent Pleural Effusion.
Pereira LJ; Mohrbacher S; Neves PDMM; Zacchi FFS; Medeiros IUD; Sato VAH; Oliveira ÉS; Pereira LVB; Cuvello-Neto AL; Baiocchi O; Chocair PR
Diagnostics (Basel); 2023 Jan; 13(3):. PubMed ID: 36766474
[TBL] [Abstract][Full Text] [Related]
26. Plants as a Source of Anticancer Agents: From Bench to Bedside.
Talib WH; Daoud S; Mahmod AI; Hamed RA; Awajan D; Abuarab SF; Odeh LH; Khater S; Al Kury LT
Molecules; 2022 Jul; 27(15):. PubMed ID: 35956766
[TBL] [Abstract][Full Text] [Related]
27. Cutaneous Involvement in Diseases with Plasma Cell Differentiation: Diagnostic Approach.
Zanelli M; Palicelli A; Sanguedolce F; Zizzo M; Filosa A; Ricci L; Cresta C; Martino G; Bisagni A; Zanetti E; di Donato F; Melli B; Soriano A; Cimino L; Cavazza A; Vivian LF; Ascani S
Curr Oncol; 2022 Apr; 29(5):3026-3043. PubMed ID: 35621636
[TBL] [Abstract][Full Text] [Related]
28. Primary Effusion Lymphoma: A Timely Review on the Association with HIV, HHV8, and EBV.
Liu CY; Chen BJ; Chuang SS
Diagnostics (Basel); 2022 Mar; 12(3):. PubMed ID: 35328266
[TBL] [Abstract][Full Text] [Related]
29. Visceral Leishmaniasis Associated with B-Cell Chronic Lymphocytic Leukemia: Report of a Case and Review of the Literature.
Zanelli M; Tafuni A; Sanguedolce F; Zizzo M; Palicelli A; Simonetti E; Scarpelli N; Quintini M; Rosignoli D; Grasselli S; Cavazza A; Martino G; Ascani S
Life (Basel); 2022 Jan; 12(2):. PubMed ID: 35207473
[TBL] [Abstract][Full Text] [Related]
30. What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review (Part 6): Correlation of PD-L1 Expression with the Status of Mismatch Repair System,
Palicelli A; Croci S; Bisagni A; Zanetti E; De Biase D; Melli B; Sanguedolce F; Ragazzi M; Zanelli M; Chaux A; Cañete-Portillo S; Bonasoni MP; Ascani S; De Leo A; Giordano G; Landriscina M; Carrieri G; Cormio L; Gandhi J; Nicoli D; Farnetti E; Piana S; Tafuni A; Bonacini M
Biomedicines; 2022 Jan; 10(2):. PubMed ID: 35203446
[TBL] [Abstract][Full Text] [Related]
31. Primary Diffuse Large B-Cell Lymphoma of the Urinary Bladder: Update on a Rare Disease and Potential Diagnostic Pitfalls.
Zanelli M; Sanguedolce F; Zizzo M; Palicelli A; Pellegrini D; Farinacci S; Soriano A; Froio E; Cormio L; Carrieri G; Cavazza A; Merli F; Pileri SA; Ascani S
Curr Oncol; 2022 Feb; 29(2):956-968. PubMed ID: 35200580
[TBL] [Abstract][Full Text] [Related]
32. Primary Effusion Lymphoma: A Clinicopathologic Perspective.
Gathers DA; Galloway E; Kelemen K; Rosenthal A; Gibson SE; Munoz J
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158997
[TBL] [Abstract][Full Text] [Related]
33. What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 7: PD-L1 Expression in Liquid Biopsy.
Palicelli A; Bonacini M; Croci S; Bisagni A; Zanetti E; De Biase D; Sanguedolce F; Ragazzi M; Zanelli M; Chaux A; Cañete-Portillo S; Bonasoni MP; Ascani S; De Leo A; Gandhi J; Tafuni A; Melli B
J Pers Med; 2021 Dec; 11(12):. PubMed ID: 34945784
[TBL] [Abstract][Full Text] [Related]
34. EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 3).
Zanelli M; Sanguedolce F; Palicelli A; Zizzo M; Martino G; Caprera C; Fragliasso V; Soriano A; Gozzi F; Cimino L; Masia F; Moretti M; Foroni M; De Marco L; Pellegrini D; De Raeve H; Ricci S; Tamagnini I; Tafuni A; Cavazza A; Merli F; Pileri SA; Ascani S
Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885131
[TBL] [Abstract][Full Text] [Related]
35. What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 1: Focus on Immunohistochemical Results with Discussion of Pre-Analytical and Interpretation Variables.
Palicelli A; Bonacini M; Croci S; Magi-Galluzzi C; Cañete-Portillo S; Chaux A; Bisagni A; Zanetti E; De Biase D; Melli B; Sanguedolce F; Ragazzi M; Bonasoni MP; Soriano A; Ascani S; Zizzo M; Castro Ruiz C; De Leo A; Giordano G; Landriscina M; Carrieri G; Cormio L; Berney DM; Athanazio D; Gandhi J; Cavazza A; Santandrea G; Tafuni A; Zanelli M
Cells; 2021 Nov; 10(11):. PubMed ID: 34831389
[TBL] [Abstract][Full Text] [Related]
36. What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 2: Clinic-Pathologic Correlations.
Palicelli A; Bonacini M; Croci S; Magi-Galluzzi C; Cañete-Portillo S; Chaux A; Bisagni A; Zanetti E; De Biase D; Melli B; Sanguedolce F; Zanelli M; Bonasoni MP; De Marco L; Soriano A; Ascani S; Zizzo M; Castro Ruiz C; De Leo A; Giordano G; Landriscina M; Carrieri G; Cormio L; Berney DM; Gandhi J; Santandrea G; Gelli MC; Tafuni A; Ragazzi M
Cells; 2021 Nov; 10(11):. PubMed ID: 34831388
[TBL] [Abstract][Full Text] [Related]
37. What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 3: PD-L1, Intracellular Signaling Pathways and Tumor Microenvironment.
Palicelli A; Croci S; Bisagni A; Zanetti E; De Biase D; Melli B; Sanguedolce F; Ragazzi M; Zanelli M; Chaux A; Cañete-Portillo S; Bonasoni MP; Soriano A; Ascani S; Zizzo M; Castro Ruiz C; De Leo A; Giordano G; Landriscina M; Carrieri G; Cormio L; Berney DM; Gandhi J; Copelli V; Bernardelli G; Santandrea G; Bonacini M
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830209
[TBL] [Abstract][Full Text] [Related]
38. What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 5: Epigenetic Regulation of PD-L1.
Palicelli A; Croci S; Bisagni A; Zanetti E; De Biase D; Melli B; Sanguedolce F; Ragazzi M; Zanelli M; Chaux A; Cañete-Portillo S; Bonasoni MP; Soriano A; Ascani S; Zizzo M; Castro Ruiz C; De Leo A; Giordano G; Landriscina M; Carrieri G; Cormio L; Berney DM; Gandhi J; Nicoli D; Farnetti E; Santandrea G; Bonacini M
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830196
[TBL] [Abstract][Full Text] [Related]
39. What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 4: Experimental Treatments in Pre-Clinical Studies (Cell Lines and Mouse Models).
Palicelli A; Croci S; Bisagni A; Zanetti E; De Biase D; Melli B; Sanguedolce F; Ragazzi M; Zanelli M; Chaux A; Cañete-Portillo S; Bonasoni MP; Soriano A; Ascani S; Zizzo M; Castro Ruiz C; De Leo A; Giordano G; Landriscina M; Carrieri G; Cormio L; Berney DM; Gandhi J; Santandrea G; Bonacini M
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830179
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
